$name |Dansac NZ

Dansac Official Statement Related to Product Supply and the 2019 Novel Coronavirus (COVID-19)

  • 13/03/2020
  • Corporate

The spread of the 2019 Novel Coronavirus (COVID-19) has raised concerns about the continued availability of medical products.

At this time, we do not anticipate any impact to our ability to supply our ostomy products to our current customers or others in need.

“From the very beginning, our Mission has been to make life more rewarding and dignified for the people who use our products and services,” said V. George Maliekel, President and CEO, Hollister Incorporated, parent company of Dansac Ostomy. “It is our priority to provide the continued flow of products to our customers who are at the center of everything we do.”

Our manufacturing facilities located in Denmark, the United States, Ireland, and Lithuania are working diligently to meet ongoing supply needs.

We will continue to monitor the Coronavirus (COVID-19) situation and will share new developments in relation to maintaining supply as appropriate.

If you have any questions or concerns, please contact your local Customer Service team on 0800 678 669 or NZcustomerservice@libmed.co.nz.

The information provided herein is not medical advice and is not intended to substitute for the advice of your personal physician or other healthcare provider. This information should not be used to seek help in a medical emergency. If you experience a medical emergency, seek medical treatment in person immediately.